![Mert Aktar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mert Aktar
Direktor/Vorstandsmitglied bei
KYVERNA THERAPEUTICS, INC.
Vermögen: 185 114 $ am 31.05.2026
Profil
Mert Aktar is currently Director at ReAlta Life Sciences, Inc. since 2024, Independent Director at Kyverna Therapeutics, Inc. since 2024, and Director at UCLA Technology Development Group since 2022.
Formerly, Mr. Aktar was Head of Business & Corporate Development at Cogent Biosciences, Inc. from 2019 to 2020.
Education includes graduate studies at Tufts University, undergraduate studies at Worcester Polytechnic Institute, and an MBA from MIT Sloan School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.05.2026 | 21’727 ( 0.04% ) | 185 114 $ | 31.05.2026 |
Aktive Positionen von Mert Aktar
| Unternehmen | Position | Beginn |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 20.10.2024 |
ReAlta Life Sciences, Inc.
 ReAlta Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel class of drugs with dual-targeting therapeutic capabilities | Direktor/Vorstandsmitglied | 01.01.2024 |
Ucla Technology Development Group
 Ucla Technology Development Group Miscellaneous Commercial ServicesCommercial Services Engages in provision of intellectual property rights | Direktor/Vorstandsmitglied | 01.11.2022 |
Ehemalige bekannte Positionen von Mert Aktar
| Unternehmen | Position | Ende |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Corporate Officer/Principal | 01.03.2020 |
Ausbildung von Mert Aktar
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Worcester Polytechnic Institute
 Worcester Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ucla Technology Development Group
Ucla Technology Development Group Miscellaneous Commercial ServicesCommercial Services Engages in provision of intellectual property rights | Commercial Services |
ReAlta Life Sciences, Inc.
ReAlta Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel class of drugs with dual-targeting therapeutic capabilities | Health Technology |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
